Intercept Pharmaceuticals (NASDAQ: ICPT) has recently received a number of price target changes and ratings updates: 10/13/2015 – Intercept Pharmaceuticals was upgraded by analysts at Vetr from a “buy” rating to a “strong-buy” rating. They now have a $200.53 price target on the stock. 10/7/2015 – Intercept Pharmaceuticals was downgraded by analysts at Vetr from […]
